In the News

400 News Items found
Pictured: Joan Massagué
In the Lab
A team of investigators from Memorial Sloan Kettering has shown for the first time that tumor growth, metastasis, and chemotherapy resistance are connected to the same molecular changes inside breast cancer cells.
a cartoon of a cancer cell spooning glutamine from a jar
Feature
While sugar gets most of the attention as a cancer fuel, other nutrients can be equally important.
A man in his 70s (prostate cancer patient) smiling for camera
A new technology shows great promise for imaging and treating advanced forms of prostate cancer.
Pouring white wine into a glass
Feature
Hear from our experts about a new study linking alcohol consumption and melanoma risk.
Julia Glade Bender and her niece Emily
MSK doctors, such as Julia Glade Bender, are achieving better outcomes for patients by personalizing treatment on the basis of the biology of the cancer rather than the patient’s age.
Left-handed and right-handed KRas molecules
In the Lab
MSK chemists are focusing on developing small-molecule drugs to target KRas, an important cancer protein.
American Association for Cancer Research
Physician-in-Chief Lisa M. DeAngelis joins healthcare experts during the AACR Virtual Meeting: COVID-19 and Cancer to discuss how to safely bring patients to the clinic so they can receive vital cancer screenings and care.
Pictured: Filippo Giancotti
In the Lab
A new Memorial Sloan Kettering study has identified one of the proteins fueling the spread of some breast cancers, and researchers hope their findings will lead to the development of new diagnostic tools and drugs.
Close up of microscope viewer.
Article
MSK Research Highlights, October 15, 2024
New MSK research identifies a gene mutation associated with resistance to breast cancer treatment; reports encouraging results for expanding use of a new prostate cancer radiotherapy; determines the best radiation level for avoiding complications treating spinal tumors; and finds that proton therapy is effective against previously treated head and neck cancers.
Nathanael Gray, Joshua Mendell, and Christopher Vakoc
Announcement
Memorial Sloan Kettering has named three winners of this year’s Paul Marks Prize for Cancer Research, an award that recognizes promising investigators.